ENTRY       D11696                      Drug
NAME        Crovalimab (USAN/INN);
            Crovalimab (genetical recombination) (JAN)
FORMULA     C6430H9974N1726O2026S46
EXACT_MASS  145257.7649
MOL_WEIGHT  145347.3332
SEQUENCE    (Heavy chain)
            QVQLVESGGG LVQPGRSLRL SCAASGFTVH SSYYMAWVRQ APGKGLEWVG AIFTGSGAEY
            KAEWAKGRVT ISKDTSKNQV VLTMTNMDPV DTATYYCASD AGYDYPTHAM HYWGQGTLVT
            VSSASTKPGS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL
            RRGPKVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
            REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVLHEALHA HYTRKELSLS P
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQGIS SSLAWYQQKP GKAPKLLIYG ASETESGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQN TKVGSSYGNT FGGGTKVEIK RTVAAPSVFI
            FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS
            TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGEC
            (Disulfide bridge: H22-H97, H150-H206, H226-L217, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'97, H'150-H'206, H'226-L'217, H'267-H'327, H'373-H'431, L23-L88, L137-L197, L'23-L'88, L'137-L'197)
  TYPE      Peptide
EFFICACY    Anti-complement C5 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of paroxysmal nocturnal hemoglobinuria (PNH)
TARGET      C5 [HSA:727] [KO:K03994]
  PATHWAY   hsa04080(727)  Neuroactive ligand-receptor interaction
            hsa04610(727)  Complement and coagulation cascades
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                C5
                 D11696  Crovalimab (USAN/INN)
DBLINKS     CAS: 1917321-26-6
            PubChem: 405226562
///
